This document discusses retinal detachment and predisposing lesions. It defines various types of retinal breaks including flap tears, giant retinal tears, operculated holes, and atrophic holes. It also covers posterior vitreous detachment and lesions that can predispose the eye to retinal detachment such as lattice degeneration, vitreoretinal tufts, and meridional folds. The document provides guidance on prophylactic treatment of retinal breaks and discusses differential diagnosis and management of retinal detachment.
Update knowledge about Muntifocal IOL made by Asaduzzaman
Working as Associate Optometrist in Ispahani Islamia Eye Institute &Hospita, Dhaka 1215
Email:asad.optom92@yaho. com
Update knowledge about Muntifocal IOL made by Asaduzzaman
Working as Associate Optometrist in Ispahani Islamia Eye Institute &Hospita, Dhaka 1215
Email:asad.optom92@yaho. com
Tele-ophthalmology: the new normal in current timesObaidur Rehman
Â
Covers telehealth and telemedicine in general. Tele-ophthalmology development in India. Practice and patterns as defined by concerned authorities. Guidelines as set up Govt of India. Current tele-ophthalmology projects in India
Tele-ophthalmology: the new normal in current timesObaidur Rehman
Â
Covers telehealth and telemedicine in general. Tele-ophthalmology development in India. Practice and patterns as defined by concerned authorities. Guidelines as set up Govt of India. Current tele-ophthalmology projects in India
Leukocoria ( or white pupillary reflex) is an abnormal white reflection from the eye.
Leukocoria is a medical sign for a number of several conditions.
- this presentation at annual conference of the Ophthalmic department, faculty of medicine - Al-Azhar University in association with DOS & EOS Cairo, Egypt January 2017
MYOPIA , basics , causes , types and treatmentssuserde6356
Â
Myopia, also known as near-sightedness and short-sightedness, is an eye disease[5][6][7] where light from distant objects focuses in front of, instead of on, the retina.[1][2][6] As a result, distant objects appear blurry while close objects appear normal.[1] Other symptoms may include headaches and eye strain.[1][8] Severe myopia is associated with an increased risk of macular degeneration, retinal detachment, cataracts, and glaucoma.[2][9]
Myopia results from the length of the eyeball growing too long or less commonly the lens being too strong.[1][10] It is a type of refractive error.[1] Diagnosis is by the use of cycloplegics during eye examination.[11]
Tentative evidence indicates that the risk of myopia can be decreased by having young children spend more time outside.[12][13] This decrease in risk may be related to natural light exposure.[14] Myopia can be corrected with eyeglasses, contact lenses, or by refractive surgery.[1][15] Eyeglasses are the simplest and safest method of correction.[1] Contact lenses can provide a relatively wider corrected field of vision, but are associated with an increased risk of infection.[1][16] Refractive surgeries like LASIK and PRK permanently change the shape of the cornea. Surgeries like Implantable Collamer Lens (ICL) implant a lens inside the anterior chamber in front of the natural eye lens. ICL doesn't affect the cornea.[
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptxvbwani
Â
Dr Wani talks on RD for residents in KLE hospital
This is a detailed talk that deals with all aspects fo RH RD
This talk aims to clear the concepts about RD
It deals the incidence of RH Rd, pathogenesis, cliinical features , diagnosis , treatment options prognosis etc
This slide contains information regarding disorders of retina. This can be helpful for proficiency level and bachelor level nursing students. Your feedback is highly appreciated.
Similar to RETINAL DETACHMENT AND PREDISPOSING LESIONS lecture by Iddi.pptx (20)
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
Â
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
Â
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
Â
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Â
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.Â
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctorsâ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
 Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratoryÂ
 to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
Â
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
Â
M Capital Group (âMCGâ) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, âDespite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.â
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (âMTIâ) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Women's Health: Understanding Prenatal Care and Beyond
Â
RETINAL DETACHMENT AND PREDISPOSING LESIONS lecture by Iddi.pptx
1. RETINAL DETACHMENT AND
PREDISPOSING LESIONS
PRESENTER: DR. IDDI NDYABAWE
MODULATOR: DR. LUSOBYA REBECCA
DATE: FRIDAY 11/03/2022
MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES
DEPARTMENT OF OPHTHALMOLOGY
2. Outline
⢠Retinal Breaks
⢠Posterior Vitreous Detachment
⢠Lesions Predisposing Eyes to Retinal Detachment
⢠Lesions not predisposing eyes to Retinal Detachment
⢠Prophylactic treatment of Retinal breaks
⢠Retinal Detachment
⢠Differential Diagnosis of Retinal Detachment
⢠Macular Lesions Associated with Retinal Detachment
3. RETINAL BREAKS
⢠Definition: any full-thickness defect in the neurosensory retina.
⢠Clinical significance: allow fluid from vitreous to collect in the epithelioretinal
interspace, hence causing a RRD.
⢠Classification of Retinal Breaks:
-flap, or horseshoe, tears
-giant retinal tears
-operculated holes
-dialyses
-atrophic retinal holes
4. Definitions
⢠A flap tear: strip of retina is pulled anteriorly by vitreoretinal traction, following PVD or
trauma. c/o: photopsias, floaters, or both.
⢠A giant retinal tear extends 90deg (3 clock-hours) or more circumferentially. Along the
posterior edge of the vitreous base.
⢠An operculated hole occurs when traction tears a piece of retina completely free from the
adjacent retinal surface.
⢠A retinal dialysis is a circumferential, linear break at the ora serrata, with
⢠vitreous base attached to the retina posterior to the tear's edge. Commonly after blunt
trauma.
⢠An atrophic hole: not associated with vitreoretinal traction. Not linked to increased risk of
retinal detachment.
6. Traumatic breaks
⢠Blunt or penetrating eye trauma can cause retinal breaks by:
-direct retinal perforation
-contusion, or
-vitreous traction.
⢠Late occurance: vitreoretinal traction and subsequent detachment ;caused by
fibrocellular proliferation
⢠Traumatic breaks are often multiple. Commonly found in the inferotemporal
and superonasal quadrants.
7. Mechanisms of traumatic retinal breaks
⢠Blunt trauma can cause retinal breaks by direct contusive injury to the globe through 2
mechanisms:
⢠(1) coup
⢠(2) contrecoup.
⢠Blunt trauma compresses the eye along its anteroposterior axis and expands it in the
equatorial plane.
⢠Slow compression of the eye has no deleterious effect on the retina because the
vitreous body is viscoelastic.
⢠But rapid compression of the eye results in severe traction on the vitreous base that
may tear the retina.
8. .
⢠Contusion injury may cause:
-large, ragged equatorial breaks
-dialysis, or
-macular hole.
The most common injuries are dialyses, which may be as small as 1 ora bay.
Dialyses are usually located at the posterior border of the vitreous base but can
also occur at the anterior border
10. .
⢠Pathognomonic feature of ocular contusion: Avulsion of the vitreous base.
⢠Less common types of breaks caused by blunt trauma are:
-horseshoe-shaped tears
-operculated holes.
11. Trauma In Young Eyes
⢠Rarely does retina detach immediately depite high incidence of eye injury.
⢠Vitreous hasnât yet undergone syneresis
⢠With time: RD
⢠Xtics of Traumatic RD in young eyes:
-Shallow
-Multiple demarcation lines
-Subretinal deposits
-Intraretinal schisis
Exception: if there is PVS, RD occurs acutely. Resembles non-traumatic breaks
12. POSTERIOR VITREOUS DETACHMENT
DESCRIPTION
⢠A posterior vitreous detachment (PVD) is the physical separation of the cortical
vitreous from the intemallimiting membrane (ILM) of the retina.
⢠With improved imaging modalities such as high-resolution optical coherence
tomography (OCT), earlier stages of structural partial PVD are readily detectable
before symptoms occur and before acomplete PVD is present
13. EPIDEMIOLOGY
⢠The incidence of PVD increases with age.
⢠Although some estimates have indicated that 50% of phakic eyes have PVD by
the age of 50 years, this has been somewhat disputed in autopsy studies
15. Genetics
⢠Axial myopia (caused by both genetic and environmental factors) correlates
with an earlier onset of vitreous liquefaction and PVD.
⢠An earlier onset of PVD and PVD-related complications are seen in Stickler's
and Marfan's syndromes due to anomalous collagen metabolism
16. PATHOPHYSIOLOGY
⢠Liquefaction of the vitreous gel is clinically evident as optically empty vacuoles
within the vitreous cavity. This may be accompanied by coalescence of collagen
fibrils into visible strands. which may be visualized ophthalmoscopically.
⢠Decreased strength of the vitreoretinal interface is also believed to precipitate
PVD
17. ETIOPATHOGENESIS
⢠Vitreous liquefaction is detectable from early childhood and increases with
age.
⢠Significant vitreous liquefaction together with loss of cohesion of the
vitreoretinal interface combine to facilitate PVD formation.
⢠In the earliest stages of a PVD, the vitreous and the retina gradually separate.
This process often starts in the macular region, but often spares the fovea until
a later stage.
18. .
⢠Once the posterior vitreous face degrades sufficiently, liquefied vitreous can
pass abruptly through even a minute defect in the posterior vitreous face into
the subhyaloid space and this is known as an acute PVD.
⢠In areas where the ILM is especially thin (i.e., optic nerve, foveola, vitreous
base, retinal vessels), the vitreoretinal interface is especially strong. These
areas are often the last to separate from the hyaloid face.
⢠A Weiss ring is aclinical sign that confirms separation of the vitreopapillary
junction, and it typically confirms the completion of the PVD
20. Diagnosis
⢠Signs and symptoms
⢠Many patients do not present with acute symptoms when PVD occurs.
⢠Presenting symptoms include entoptic phenomena such as floaters, change
in pattern of floaters and photopsias.
⢠An alteration in peripheral visual field may indicate a retinal detachment
21. Physical exam
⢠Indirect ophthalmoscopy with scleral indentation and slit lamp exam with a three-
mirror lens are the preferred techniques to confirm PVD and to exclude retinal tears
or retinal detachment.
⢠The presence of vitreous hemorrhage or pigment may indicate a retinal tear.
⢠If significant hemorrhage interferes with complete examination, bed rest with head at 45º for hours or
days with optional bilateral ocular patching may help restore transparency in order to rule out retinal
tears. If the source of bleeding cannot be found, the patient should be re-examined regularly and
frequently with a vitrectomy considered to identify a source.
⢠Echography may be useful in detecting retinal tears with flap or retinal detachment,
especially if haemorrhage or other opacification of media limits visualization.
⢠Patients are given strict return precautions and often re-examined within 2-6 weeks
after presentation to assess for retinal breaks with a PVD in evolution.
26. Differential Diagnosis
⢠Retinal detachment
⢠Asteroid hyalosis/Synchysis scintillans
⢠Vitreous syneresis
⢠Vitreous inflammation (infectious and non infectious)
⢠Vitreous haemorrhage
⢠Vitreous amyloidosis
⢠Ocular large cell lymphoma
27. Management
⢠General treatment: Observation with strict retinal detachment precautions,
and follow up exam to rule out retinal breaks. Vitrectomy can be considered
for non-clearing vitreous hemorrhage, or vision threatening pathology.
⢠Medical therapy: There are no medical therapies recommended for a PVD.
⢠Medical follow up
After the diagnosis of an acute PVD, a follow up dilated fundus examination
should be performed approximately 1 month afterwards. It is possible for a new
retinal tear or retinal detachment to occur during this dynamic period.
28. Surgery
⢠For unmmplicated PVD, no treatment is necessary.
⢠When a retinal tear or detachment Is present, prompt treatment is
imperative.
⢠Rarely, pars plana vitrectomy may be offered to alleviate severe PV!Helated
symptoms; however, this Is the exception
⢠Surgical follow up
If surgery is performed, the recommended follow up intervals are day 1,
week 1, month 1 and month 3. Serial OCT scans are recommended to assess
for anatomic success and correlation with visual acuity outcomes.
29. ONGOING CARE
⢠Prompt evaluation by an ophthalmologist or optometrist when symptoms of
acute PVD occur
⢠Prompt referral to an ophthalmologist skilled in the treatment of retinal
tears and/or detachments In the event that one is detected
30. Patient education
⢠After an acute PVD, patients are often significantly bothered by floaters and
flashes. tt is often reassuring to let patients know that symptoms will
typically lessen within months.
⢠Patients should be educated to report the symptoms of a retinaI tear or
detachment should they occur
31. PROGNOSIS
⢠After an uncomplicated PVD, tile prognosis is excellent.
⢠In some cases. as in eyes with vitreomacular traction, visual acuity may
improve.
⢠After a complicated PVD U.e., with a retinal break), there is an elevated risk
of additional tears occurring.
⢠When a complicated PVD occurs in one eye, the fellow eye has ahigher risk of
romplications from PVD likely due to the nature ofthe vitreoretinal interface.
32. Complications
⢠Retinal tears
⢠Rhegmatogenous retinal detachment
⢠VH
Long term complications may include:
⢠vitreo-macular traction
⢠lamellar macular holes
⢠full-thickness macular holes
⢠epiretinal membrane
34. Lesions Predisposing Eyes to Retinal
Detachment
⢠Lattice Degeneration
⢠Vitreoretinal Tufts
⢠Meridional Folds, Enclosed Ora Bays, and Peripheral Retinal Excavations
35. Lattice Degeneration
⢠Vitreoretinal interface abnormality
⢠Epid: 6-10% of general population
⢠Bilateral on 1/3-1/2 of affected patients
⢠RFs: myopia, familial predilection
⢠Complications: Retinal breaks and RD
36. .
Histology:
⢠1. loss of ILM
⢠2. Vitreous liquifies in pockets
⢠3. Vitreous adheres to margins
⢠4. inner retinal atrophy
37. .
⢠Features of RD caused by Lattice Degeneration:
⢠Tractional tear at the lateral or posterior margin of lattice lesion
⢠Atrophic hole within zone of lattice
48. Meridional Folds, Enclosed Ora Bays and
Peripheral Retinal Excavations
⢠Meridional folds: folds of redundant retina. Site; Superonasal.
⢠Tears assoc with PVD occur at the most posterior limit of the folds
⢠Enclosed ora bays: oval islands of pars plana epithelium. Site; immediately
posterior to ora serrata.
⢠Retinal tears at the posterior limit.
⢠Peripheral retinal excavations: firmly attached to vitreoretinal adhesions.
Site; 4 DD posterior to ora serrata.
⢠Significance; represent a mild form of lattice degeneration.
51. Paving-Stone Degeneration
⢠Description: peripheral, small, discrete areas of atrophy of outer retina. Single
or in groups.
⢠Epid: in 22% > 20 years old
⢠Histology:
⢠atrophy of RPE and outer retinal layers
⢠Attenuation or absence of choriocapillaris
⢠Adhesions between remaining neuroepithelial layers and Bruchâs membrane
52. .
⢠CFs:
⢠Yellowish white, with rim of hypertrophic RPE
⢠Inferior quadrants, anterior to equator
54. RPE Hyperplasia
⢠Cause: chronic low grade traction
Sites:
⢠Ora serrata
⢠Pars plana
⢠Peripheral retina
⢠Areas of previous inflammation or trauma
61. Clinical significance of Retinal Breaks
⢠Majority donât cause any RD
⢠Some cause RD.
⢠Mech: fluid from vitreous thru it and separates sensory retina from the RPE
62. Prophylactic treatment of retinal breaks
⢠Prophylactic treatment aims to reduce risk of RD
⢠Options:
-Laser
-Cryotherapy
⢠Goals: create a chorioretinal adhesion around each break preventing fluid from
entering the subretinal space
⢠If subretinal fluid present, treatment applied to surround area of subretinal fluid
⢠Contraindications:
>-6 D Myopia
>6 clock-hours lattice
63. Factors to consider when considering
prophylaxis
⢠Symptoms
⢠Family history
⢠Residual traction
⢠Size and location of break
⢠Phakic status
⢠Refractive error
⢠Status of fellow eye
⢠Presence of subretinal fluid
⢠Availability of follow-up evaluation
64. Approach to prophylaxis
⢠Symptomatic retinal breaks
⢠Asymptomatic retinal breaks
⢠Lattice Degeneration
⢠Aphakia and Pseudophakia
⢠Fellow eye in patients with RD
⢠Subclinical RD
65. Symptomatic Retinal Breaks
⢠Risk of progress to RD, esp if there is VH
⢠Acute symptomatic flap tears: treated prophylactically
⢠Acute operculated holes: usually not treated. Less likely to cause RD.
⢠Indications for prophylaxis here:
⢠Persistent vitreous traction at margin of operculated hole
⢠If hole is large or located superiorly
⢠VH
⢠Atrophic holes: donât require treatment. Incidental findings.
66. Asymptomatic Retinal Breaks
⢠Asymptomatic flap tears: not treated if in emmetrophic phakic eyes.
⢠When to treat them:
⢠Lattice degeneration
⢠Myopia
⢠Subclinical detachment
⢠Aphakia
⢠h/o RD in fellow eye
⢠Asymptomatic operculated holes and atrophic holes: rarely treated.
67. Lattice degeneration
⢠Limited data
⢠Doesnât require prophylaxis if no risk factors
⢠Which additional risk factors warrant treatment?
⢠RD in fellow eye
⢠Flap tears
⢠Aphakia
68. Aphakia and pseudophakia
⢠Higher risks of RD than phakic eyes
⢠RFs for developing RD after cataract surgery:
-Male sex
-Younger age
-Myopia
-Increased axial length
-Posterior capsular tear
69. Fellow eye in patients with RD
If a patient has RD in one eye, fellow eye risk of RD is:
⢠10% for phakic RD
⢠25% for aphakic RD
⢠35% for pseudophakic RD
Rx: prophylactic treatment of flap tears and lattice degeneration
70. Subclinical Retinal Detachment
⢠Definition: a detachment where subretinal fluid extends > 1 DD from the break
but not more than 2 DD posterior to the equator.
⢠Significance: 30% progress to RD
⢠Indications for treatment:
-Symptomatic patients
-Cases involving traction on the break
74. RETINAL DETACHMENT
⢠Neuroepithelium and the pigmentary epithelium of the retina normally lie in
apposition with the potential space bewtween the (original primary optic
vesicle)
⢠Retinal detachment occurs when subretinal fluid accumulates in the potential
space between the neurosensory retina and the underlying retinal pigment
epithelium.
75. Epidemiology
⢠incidence of approximately 1 in 10000
⢠very rare in children
⢠Most common between 40 to 70 years old.
⢠Natural ageing changes in the vitreous gel, known as PVD, can cause retinal tears and PVD is more common as you get older.
76. RISK FACTORS FOR RD
⢠Lattice degeneration
⢠Peripheral retinal breaks
⢠Pathologic myopia
⢠Previous intraocular surgery
⢠Trauma
⢠Previous retinal detachment
⢠Family history
77. CLASSIFICATION
⢠Depending on the mechanism of subretinal fluid accumulation, retinal detachments
traditionally have been classifird into:
-Rhegmatogenous
-Tractional
-Exudative
⢠Clinically:
⢠1) Primary detachments: detachments due to the development of a break in the
retina, in which case the state of this tissue is of primary importance
(rhegmatogenous)
⢠2) Secondary detachments: due to an obvious mechanical cause â when the
detachment is because of another disease process in the eye
78. .
⢠A) Exudation: exudative choroiditis or retnopathy, angiomatous, toxemia of
pregnancy fluid may be blood (as from a chroroidal hemorrhage)
⢠Pathophysiology: association of subretinal fluid to absence of traction and
break.
⢠Retinal signs: convex configuration of RD, mobile detached retina, shifting fluid
+
80. .
⢠B) Traction: plastic cyclitis, proliferative retinopahty (diabetic mostly) or ROP,
penetrating posterior segment trauma
⢠Pathophysiology: retina being mechanically pulled away from its bed by the
contraction of fibrous tissue in the vitreous in absence of retinal tear
⢠Retinal signs: concave configuration o RD. Severely reduced retinal mobility
and absence of drifting fluid
⢠Combined Tractional Rhegmatogenous RD â Retinal break is caused by traction
from an adjacent area of fibrovascular proliferation.
81. Diagnosis
⢠History:
⢠significant photopsias and/or persistent new floaters
⢠constant fixed or slowly progressive visual field loss.
⢠Important information to elicit:
-onset of symptoms
-presence and duration of decreased central visual acuity
-prior trauma
-prior surgery
-hemorrhage
-complete past medical history and review of systems.
82. Physical examination
⢠Visual acuity, pupillary examination, visual field testing, intraocular pressure, color vision.
⢠Slit lamp examination of the anterior segment.
⢠Examination of the anterior vitreous for pigment (Schaffer's sign) or vitreous hemorrhage is
critical.
⢠A thorough fundus examination to include indirect ophthalmoscopy with scleral depression and
visualization to the ora serrata should be completed. A detailed drawing describing the
detachment with location of retinal pathology may be documented.
⢠If there is no view to the posterior pole such as in hemorrhage or media opacity, B-scan
ultrasound should be used to evaluate the retinal and vitreous status.
91. Lab tests
⢠Indication: If a cause for the traction retinal detachment cannot be determined by
history, further laboratory analysis may be required to determine if diabetes, sickle
cell, carotid disease or another systemic or ocular process is the source for
proliferative retinopathy.
⢠Since exudative detachments may be due to a systemic or ocular inflammatory
process, laboratory investigation may be indicated. Here, fluorescein angiography
may be indicated to further clarify exudative processes such as macular
degeneration, central serous chorioretinopathy, and Vogt-Koyanagi-Harada syndrome
or other uveitic processes.
⢠Ultrasound is a useful imaging modality to evaluate choroidal masses or posterior
scleritis.
92. Rhegmatogenous RD
⢠Characterised by the presence of a retinal break in concert with vitreoretinal
traction that allows accumulation of liquefied vitreous under the neurosensory
retina, separating it from the RPE
⢠Even though a retinal break is present, a RD will almost never occur if the
vitreous is not at least partially liquefied and traction is absent
93. RRD cont
⢠Risk factors:
⢠Myopia, PVD,Vitreous loss following cataract surgery and laer capsulotomy.
⢠Aphakia, RD in other eye. Persistent vitreoretinal traction, blunt and
penetrating trauma.
⢠Retinal breaks: retinal breaks may be flat or associated with a surrounding
cuff of SRF.
⢠The shape of such breaks varies.
⢠Breaks can be round holes, horseshoe-shaped tears, operculated tears or
retinal disinsertion at the ora (dialysis)
95. .
⢠A retinal break is identified and localized in most eyes with RRD, 50% have
more than one break.
⢠More than half of all retinal breaks are located in the upper temporal quadrant,
although any quadrant may be affected
⢠SRF spread is governed by gravity, by anatomical limits (ora serrata and optic
nerve) and by the location of the primary retinal break
⢠The likely location of primary retinal break can be predicted by studying the
shape of RD by Lincoff rule:
96. Lincoff rules
⢠A superior retinal detachment extending downwards equally on both sides of the
macula is commonly found to have a retinal break present within a clock hour of 12
oâclock.
⢠An inferior retinal detachment extending upwards equally on both sides of the
macula is commonly found to have a retinal break present within a clock hour of 6
oâclock
⢠Asymmetrical distribution of subretinal fluid (SRF) points to the presence of a retinal
break within one to two clock hours of the edge of the more vertically extensive
retinal detachment
100. Symptoms
⢠Classic premonitory sumptoms in patients with complete RRD: flashing lights
(photopsia) and floaters associated with acute PVD
⢠After a variable period of time a curtain-like relative peripheral visual field
defect may ensue, and can progress to involve the central vision.
101. General signs
⢠RAPD: present in an eye with extensive RD
⢠IOP is often lower by about 5mmHg compared with the normal eye
⢠Iritis is very common but usually mild
⢠âTobacco dustâ (Shaffer sign) consisting of pigment cells is commonly seen in
the anterior vitreous, subretinal vitreous blood or inflammatory cells are also
highly specific
102. .
⢠Retinal breaks appear as discontinuaties in the retinal surface. They are
usually red.
⢠Retinal signs:
⢠Early stages:
⢠In the most typical condition it is white or gray, with folds which show a
bright sheen at the summits and appear gray in the depressions
⢠During the slight movements of the eye the folds show oscillations and the
retinal vessels are seen coursing over the surface.
104. .
⢠Extensive detachment: great ballon-like folds may be seen, and then may cut
off all view of the disc (bullous RD)
⢠Detached retina: slightly opaque colour secondary to intraretinal edema and
the normal choroidal pattern of vessels is no longer seen.
⢠It has a convex configuration, and moves freely with eye movements unless
proliferative vitreoretinopathy (PVR) is present
105. .
⢠At the edges of the detachment a considerable degree of pigmentary
disturbance may appear, as well as white spots of exudation, hemorrhages and
greyish-white lines due to the retinal folds.
⢠In total detachment the retina is funnel shaped, remaining attached at the
disc and at the ora serrata.
⢠Still later it becomes largely bunched behind the lens, the part attached to
the disc being pulled out into a straight cord.
106. Long-standing
⢠More fixed folds
⢠Retinal thinning
⢠Intraretinal cysts
⢠Subretinal fibrosis
⢠Subretinal demarcation lines: present usually at the junction of the attached
and detached retina
⢠Represent areas of increased retinal adhesion to the RPE.
⢠Subretinal fluid may spread beyond the lines.
107.
108. PROPHYLAXIS FOR RD
⢠Prophylaxis of retinal detachment is best done by identifying predisposing
retinal breaks and other lesions, and treating them with cryotherapy or laser
especially if other risk factors are present.
⢠Even after prophylactic treatment, a lifelong followup of such eyes is
essential.
⢠Asymptomatic patients with peripheral retinal degenerations that could lead
on to a retinal break, e.g lattice degeneration, have a low risk of retinal
detachment and require only periodic review.
109. MANAGEMENT OF RD
⢠Operations for retinal detachment can be successfully performed only after
accurate localization of all retinal breaks
⢠SURGICAL MANAGEMENT:
⢠Depends on the extent and duration of the condition and the condition of the
retina.
110. PRINCIPLES OF SURGERY
⢠Common principles used in all types of surgery to treat a retinal detachment are as
follows:
1. Identification of all retinal breaks and areas of vitreous or periretinal traction
2. Induction of aseptic chorioretinal inflammation around the breaks to seal them
3. Release of any vitreous or periretinal traction
4. Drainage of subretinal fluid and
5. Ensuring chorioretinal apposition for at least a couple of weeks by either or both of
the following:
⢠A) External tamponade: silicone buckle, sponge, tyre, encircling band
⢠B) Internal tamponade; air, gases such as Sulphur hexafluoride (SF6), perfluoropropane
(C3F8), or liquids such as silicone oil.
111. Pneumatic retinopexy
⢠Involves the injection of an intraocular gas bubble along with retinopexy
using cryotherapy or laser, typically in a clinic setting.
⢠An important part in the successful repair of retinal detachment with
pneumatic retinopexy involves head positioning so that the gas bubble
tamponades the retinal tear.
⢠Pneumatic retinopexy is typically only used with retinal detachments due to
retinal tears in the superior eight clock hours and involving a single break
less than one clock hour.
114. Scleral buckling
⢠Scleral buckles are silicone bands permanently placed around the outside of
the globe under the extraocular rectus muscles to relieve any traction and
support retinal tears.
⢠Scleral buckling is combined with retinopexy, typically cryotherapy.
⢠This is the oldest method of repair and still has excellent results in well-
trained hands.
116. Pars plana vitrectomy
⢠Pars plana vitrectomy with 20 gauge, 23 gauge, 25 gauge, or 27 gauge
instruments involves removal of the vitreous by way of cutting the vitreous
strands with a vitrectomy machine/handpiece and flattening of the retina
through a direct intraocular process
118. Proliferative Vitreoretinopathy
⢠Most common complication following a RRD. Most common cause of failure of retinal repair.
⢠Caused by epiretinal and subretinal membrane formation, contraction leads to tangential
retinal traction and fixed retinal fold formation
⢠Main features are retinal folds and rigidity so that retinal mobility induced by eye movements
is decreased
⢠Noted as:
⢠Stage A: minimal
⢠Stage B: moderate
⢠Stage C: marked
⢠Stage D: massive and the number of quadrants is recorded as 1-4
⢠This scar tissue exerts traction on the retina and may result in recurrence of the retinal
detachment, even after an initially successful retinal reattachment procedure
⢠Rx: surgical intervention to release the traction caused by membranes
120. Risk factors for PVR include
⢠Age
⢠Giant retinal tears
⢠Retinal detachments involving more than 2 quadrants
⢠Previous retinal detachment repair
⢠Use of cryotherapy
⢠Vitreous hemorrhage
⢠Choroidal detachment.
⢠Trauma
121. Macular Lesions Associated With Retinal
Detachment
⢠Optic Pit Maculopathy
⢠Macular Holes in High Myopia
122. Optic Pit Maculopathy
⢠Definition: small, hypopigmented, yellow or whitish, oval or round, excavated
colobomatous defects of the optic nerve; they are usually found within the
inferior temporal portion of the optic disc margin
⢠Significance: may lead to serous macular detachments with a poor prognosis if
left untreated
⢠Rx: vitrectomy with gas-bubble placement
124. Macular Holes in High Myopia
⢠A distinct variant of RRD is caused by macular holes, almost always in the
setting of a posterior staphyloma of highly myopic eyes
⢠Vitreous cavity fluid enters the subretinal space through the macular hole, and
the relative recoil forces of the stretched macular retina lining the staphyloma
help initiate the detachment.
⢠These macular holes with retinal detachment have a far lower success rate for
surgical repair than do either macular holes or typical RRDs